Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Cash Flows

v3.22.2.2
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities    
Net income (loss) $ (548) $ (10,429)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Depreciation, amortization and accretion expense 26,219 935
Amortization of debt issuance costs 1,404 14
Amortization of intangibles and below-market contracts (2,206) 0
Bad debt expense 76 9
Return on investment in equity method investments 8,910 0
Equity in earnings of equity method investments (4,122) 0
Total (gains) losses on derivatives, net (18,180) 0
Net cash received (paid) in settlement of derivatives (200)  
Net cash received (paid) in settlement of derivatives   0
Forgiveness of Paycheck Protection Loan 0 (201)
Share-based compensation expense 8,923 179
Changes in operating assets and liabilities:    
Accounts receivable 7,129 441
Inventory (1,886) 0
Prepaid expenses and other current assets 2,737 (618)
Accounts payable - trade 17,974 1,961
Accrued and other liabilities 11,458 180
Other non-current assets (969) 0
Other long-term liabilities (27) 19
Net cash provided by (used in) operating activities 56,692 (7,510)
Cash flows from investing activities    
Acquisition of Aria, net of cash acquired 1,876 0
Acquisition of assets and businesses (7,013) (31,527)
Additions to property, plant and equipment and progress payments (127,889) (56,609)
Contributions to equity method investments (8,027) 0
Return of investment in equity method investments 7,422 0
Net cash used in investing activities (133,631) (88,136)
Cash flows from financing activities    
Borrowings on line of credit agreement 0 8,578
Repayments on line of credit agreement 0 (1,522)
Proceeds from long-term debt, net of issuance costs 225,339 123,641
Repayments of long-term debt (2,875) (314)
Payment of acquisition contingent consideration (1,650) 0
Capital contributions 0 70
Taxes paid on net share settled stock-based compensation awards (1,762) 0
Net cash provided by financing activities 219,052 130,453
Net change in cash, cash equivalents and restricted cash 142,113 34,807
Cash, cash equivalents and restricted cash - beginning of period 93,066 1,496
Cash, cash equivalents and restricted cash - end of period 235,179 36,303
Supplemental cash flow information    
Cash paid for interest 8,834 2,333
Non-cash investing activities    
Accruals of property, plant and equipment and biogas rights incurred but not paid $ 36,499 $ 10,965